Share This Link

A pH of 7.48 and bicarbonate of 32 mEq/L indicate metabolic alkalosis. This is an expected finding due to gastric acid loss from vomiting. While abnormal, it does not pose an immediate life-threatening crisis compared to myocardial instability.

A serum chloride level of 88 mEq/L represents hypochloremia. This occurs from losing chloride ions in gastric secretions during emesis. Mild muscle cramping is expected, but this condition is stable and does not indicate imminent cardiac arrest.

A pH of 7.32 and bicarbonate of 18 mEq/L indicate metabolic acidosis. This can happen in bulimia if the client misuses laxatives rather than vomiting. Although requiring intervention, this metabolic state lacks the immediate lethal risk of telemetry changes.

The client's sodium level increased slightly from 135 mEq/L to 142 mEq/L. This value remains within the normal physiological range of 135 to 145 mEq/L. It reflects mild fluid balance regulation during nutritional rehabilitation. This expected shift does not indicate a metabolic emergency or refeeding pathology.

Blood urea nitrogen decreased from 22 mg/dL to 14 mg/dL. This represents a positive trend toward normal hydration and improved protein utilization status. The current value is within the standard reference range of 6 to 20 mg/dL. It does not signify an acute or life-threatening crisis requiring clinical prioritization.

Serum calcium decreased minimally from 9.2 mg/dL to 8.8 mg/dL. While hypocalcemia can occur, this value is within the normal range of 8.5 to 10.5 mg/dL. It does not represent a critical hallmark shift of refeeding syndrome. Therefore, it is a low-priority finding that indicates a stable homeostatic state.

Fluoxetine 60 mg daily is the standard evidence-based dosage for bulimia nervosa. This selective serotonin reuptake inhibitor targets both binge-purge behaviors and co-occurring depression. It represents the preferred first-line psychopharmacological intervention. The nurse would not clarify this appropriate therapeutic clinical prescription.

Sertraline 100 mg daily is a safe choice for managing comorbid major depressive disorder. It helps stabilize mood without increasing the client's neurological seizure susceptibility. This therapeutic dose fits within standard clinical safety parameters for depressive illnesses. Therefore, it does not require an urgent clarification.

Mirtazapine 15 mg at bedtime is an effective antidepressant that may benefit select clients. Its side effect profile includes weight gain, which requires careful clinical consideration but remains a viable alternative. It does not pose an acute life-threatening danger. This makes it a low-priority prescription for provider clarification.

A Mallory-Weiss tear is a superficial, non-transmural mucosal laceration at the gastroesophageal junction. It typically presents with painless or mildly painful hematemesis rather than severe retrosternal chest pain, crepitus, or septic fever. This diagnosis lacks life-threatening mediastinal compromise.

Reflux esophagitis involves acute inflammation from chronic gastric acid exposure. While it causes substernal burning pain, it does not present with subcutaneous crepitus or septic fever. It represents a chronic irritation process rather than an acute, catastrophic esophageal wall integrity failure.

Achalasia involves the destruction of the myenteric plexus, leading to esophageal dilation and impaired peristalsis. It presents with progressive dysphagia and regurgitation, not sudden chest pain or mediastinal air leakage. This condition is unrelated to the acute mechanical injury described.